Page 4 - CBCMT-Pulse_Vol-2
P. 4

About CBCMT…





         Centre for Biomaterials, Cellular and Molecular Theranostics (CBCMT) was established in
         the year 2016 as an integral part of VIT, under the able leadership of Prof. Geetha
         Manivasagam This interdisciplinary research centre
         Manivasagam.
         works on cutting edge technologies at the interface
         of physical, biological, chemical and engineering
         sciences. The research team comprises of material
         scientists,  biologists,  physicists,  mechanical
         engineers, bioengineers, chemists and clinicians,
         who collaborate to address the unmet needs in the
         areas of biomaterials, cellular and molecular
         theranostics. Some of the primary focus areas
         include soft and hard tissue engineering,  in vitro
         model of bone tumors, dental materials, biocorrosion, biomechanics, drug discovery,
         sensors for microbe detection and implant for health monitoring.
         CBCMT is equipped with cutting-edge instruments to conduct experiments ranging from
         material synthesis, material processing, characterizations, evaluating performance of
         medical implants through tribocorrosion, mechanical characterization and wettability, as
         well as advanced cell culture experiments. CBCMT’s HOME (Human Organ Manufacturing
         and Engineering) Lab is an advanced 3D bioprinting facility equipped with bioprinters, cell
         culture facility and a Confocal Laser Scanning Microscope. The ongoing projects of the
         centre are funded by both national and international funding agencies. The centre also has
         a strong research collaboration with clinicians and scientists from leading research
         laboratories within India as well as across the globe.

                    VISION                        MISSION                      VALUES















               CBCMT thrives to be            To provide state-of-       Quality   -  Excellent
               the hub of translational       the-art   health-care      research          with
               research in order to           options for patients by    translational impact
               address   the   unmet          developing   efficient,    Growth - Innovation,
               needs     in   treating        cost-effective   and       continued development
               several critical disorders     safe        treatment      and           improved
               through cutting edge           strategies   through       performance
               technologies                   multi-disciplinary         Integrity - Maintaining
                                              research                   highest  standard   of
                                                                         ethics in research
                                                                         Accountability       -
                                                                         Social and scientific
                                                                         responsibility

      CBCMT Pulse   August 2022  Volume 2                                                              2
   1   2   3   4   5   6   7   8   9